Connor, Clark & Lunn Investment Management Ltd. Emergent Bio Solutions Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 931,627 shares of EBS stock, worth $5.64 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
931,627
Previous 902,332
3.25%
Holding current value
$5.64 Million
Previous $8.63 Million
47.52%
% of portfolio
0.02%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding EBS
# of Institutions
177Shares Held
38.3MCall Options Held
94.1KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$23.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$19.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$15.1 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$13.9 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$10.4 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $302M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...